IL6 and Alzheimer disease: In contrast, AD-MSCs tend to produce a more tissue-specific secretome with relatively higher concentrations of interleukin 6 (IL-6), membrane cofactor protein 1 (MCP-1), and matrix metalloproteinases (MMPs), which support localized repair but offer limited systemic paracrine signaling [7,13,17,22].